The oncogene function of the PBX1 protein was first reported in acute lymphoblastic leukemia, where t (1:19), a translocation mutation event, resulted in the fusion of the E2A and PBX1 genes and enhanced PBX1 expression [6]. This evidence concerns the gene PBX1 and acute lymphoblastic leukemia.